| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/27/2023 | 24.58% | UBS | → $115 | Initiates Coverage On | → Buy |
| 09/05/2023 | 26.75% | Goldman Sachs | $93 → $117 | Upgrades | Neutral → Buy |
| 07/14/2023 | 27.83% | Truist Securities | $107 → $118 | Maintains | Buy |
| 02/14/2023 | 17% | Benchmark | $88 → $108 | Maintains | Buy |
| 02/09/2023 | 19.16% | Loop Capital | $95 → $110 | Maintains | Buy |
| 02/09/2023 | 11.58% | Truist Securities | $93 → $103 | Maintains | Buy |
| 02/09/2023 | -5.75% | Goldman Sachs | $76 → $87 | Maintains | Neutral |
| 11/22/2022 | -6.84% | Jefferies | → $86 | Initiates Coverage On | → Hold |
| 11/03/2022 | -17.67% | Goldman Sachs | $67 → $76 | Maintains | Neutral |
| 08/04/2022 | -27.42% | Goldman Sachs | $59 → $67 | Maintains | Neutral |
| 04/20/2022 | -40.42% | Goldman Sachs | $57 → $55 | Upgrades | Sell → Neutral |
| 04/08/2022 | -29.59% | Truist Securities | $86 → $65 | Maintains | Buy |
| 09/09/2021 | -26.34% | Canaccord Genuity | $53 → $68 | Upgrades | Hold → Buy |
| 08/06/2021 | -50.17% | Goldman Sachs | $39 → $46 | Maintains | Sell |
| 05/07/2021 | -33.92% | Stifel | $47 → $61 | Upgrades | Hold → Buy |
| 02/11/2021 | -49.08% | Canaccord Genuity | $46 → $47 | Maintains | Hold |
| 07/07/2020 | -59.92% | JP Morgan | $40 → $37 | Maintains | Neutral |
| 04/30/2020 | -61% | Canaccord Genuity | $52 → $36 | Maintains | Buy |
| 04/30/2020 | -48% | SunTrust Robinson Humphrey | $47 → $48 | Maintains | Buy |
| 04/21/2020 | -62.63% | Stifel | → $34.5 | Downgrades | Buy → Hold |
| 04/13/2020 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
| 03/16/2020 | -49.08% | SunTrust Robinson Humphrey | $56 → $47 | Upgrades | Hold → Buy |
| 03/03/2020 | -32.84% | Longbow Research | → $62 | Upgrades | Neutral → Buy |
| 02/13/2020 | -35% | Stifel | $63 → $60 | Maintains | Buy |
| 01/23/2020 | — | Cross Research | Downgrades | Hold → Sell | |
| 08/01/2019 | -38.25% | Stifel | $70 → $57 | Maintains | Buy |
| 02/21/2019 | — | Longbow Research | Downgrades | Buy → Neutral | |
| 01/03/2019 | — | Longbow Research | Upgrades | Neutral → Buy | |
| 12/03/2018 | -40.42% | Goldman Sachs | → $55 | Downgrades | Buy → Neutral |
| 11/01/2018 | -29.59% | Canaccord Genuity | $88 → $65 | Maintains | Buy |
| 11/01/2018 | — | SunTrust Robinson Humphrey | Downgrades | Buy → Hold |
What is the target price for Belden (BDC)?
The latest price target for Belden (NYSE: BDC) was reported by UBS on September 27, 2023. The analyst firm set a price target for $115.00 expecting BDC to rise to within 12 months (a possible 24.58% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Belden (BDC)?
The latest analyst rating for Belden (NYSE: BDC) was provided by UBS, and Belden initiated their buy rating.
When is the next analyst rating going to be posted or updated for Belden (BDC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Belden, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Belden was filed on September 27, 2023 so you should expect the next rating to be made available sometime around September 27, 2024.
Is the Analyst Rating Belden (BDC) correct?
While ratings are subjective and will change, the latest Belden (BDC) rating was a initiated with a price target of $0.00 to $115.00. The current price Belden (BDC) is trading at is $92.31, which is within the analyst's predicted range.